Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2001

View Archived Issues

VEGF gene therapy improves clinical status, myocardial perfusion and ischemia in angina

New treatment regimens of Zithromax recommended for approval in pediatric ear infections

Preclinical milestone achieved for SignalGene's SERM compounds

Preclinical results further validate Islet Neogenesis Therapy for diabetes

Ethics committee approval granted for PI-88 phase II trial in multiple myeloma

BioSante licenses vaccine technology to Corixa

Revised phase III plans for Endovasc's NRA and Liprostin

Traditional medicine used in Korea inhibits behavioral effects of psychostimulants

AMPA receptor antagonist ER-167288-01 ameliorates neurological status in MS model

Antioxidant strategy based on targeted enzyme induction may be beneficial in MS

Preclinical evidence supports the therapeutic potential of dexefaroxan in AD

Neurochemical effects of selective, oral AChE inhibitor from Chiesi studied in rats

Lundbeck offers interim progress report

Factor Xa inhibitor as a novel therapeutic agent in embolic stroke

New caspase inhibitor limits infarct size in rat model of cardiac ischemia/reperfusion injury

Prevention of carotid artery intimal hyperplasia by oral chymase inhibitor

FDA approves frovatriptan for treatment of migraine

Termination of PSVT with CVT-510 associated with fewer arrhythmias than adenosine

ImmunoGen highlights Q1 development progress

Enzyme targets for therapeutic intervention in AD

Use of growth factor in erectile dysfunction

Cathepsin K inhibitors and their use described in recent patent

Treatment of inflammatory and autoimmune diseases with new IL-2 inhibitors

MethylGene patents new histone deacetylase inhibitors for use in neoplastic diseases

Pharma Mar identifies novel antitumor compounds from marine sponge

Acetamide-based thrombin inhibitors synthesized at Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...